These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11395575)

  • 1. Treatment of drug-resistant human neuroblastoma cells with cyclodextrin inclusion complexes of aphidicolin.
    Michaelis M; Cinatl J; Vogel JU; Pouckova P; Driever PH; Cinatl J
    Anticancer Drugs; 2001 Jun; 12(5):467-73. PubMed ID: 11395575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity of aphidicolin and its derivatives against neuroblastoma cells in vitro: synergism with doxorubicin and vincristine.
    Michaelis M; Vogel JU; Cinatl J; Langer K; Kreuter J; Schwabe D; Driever PH; Cinatl J
    Anticancer Drugs; 2000 Jul; 11(6):479-85. PubMed ID: 11001389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of resistance to vincristine and doxorubicin in neuroblastoma alters malignant properties and induces additional karyotype changes: a preclinical model.
    Kotchetkov R; Cinatl J; Blaheta R; Vogel JU; Karaskova J; Squire J; Hernáiz Driever P; Klingebiel T; Cinatl J
    Int J Cancer; 2003 Mar; 104(1):36-43. PubMed ID: 12532417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased systemic efficacy of aphidicolin encapsulated in liposomes.
    Michaelis M; Zimmer A; Handjou N; Cinatl J; Cinatl J
    Oncol Rep; 2005 Jan; 13(1):157-60. PubMed ID: 15583818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproic acid inhibits adhesion of vincristine- and cisplatin-resistant neuroblastoma tumour cells to endothelium.
    Blaheta RA; Michaelis M; Natsheh I; Hasenberg C; Weich E; Relja B; Jonas D; Doerr HW; Cinatl J
    Br J Cancer; 2007 Jun; 96(11):1699-706. PubMed ID: 17505515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aphidicolin glycinate inhibits human neuroblastoma cell growth in vivo.
    Cinatl J; Cinatl J; Kotchetkov R; Driever PH; Bertels S; Siems K; Jas G; Bindseil K; Rabenau HF; Pouckova P; Doerr HW; Schwabe D
    Oncol Rep; 1999; 6(3):563-8. PubMed ID: 10203592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of drug-resistant neuroblastoma cell lines by comparative genomic hybridization.
    Bedrnicek J; Vicha A; Jarosova M; Holzerova M; Cinatl J; Michaelis M; Cinatl J; Eckschlager T
    Neoplasma; 2005; 52(5):415-9. PubMed ID: 16151587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoresistance induces enhanced adhesion and transendothelial penetration of neuroblastoma cells by down-regulating NCAM surface expression.
    Blaheta RA; Daher FH; Michaelis M; Hasenberg C; Weich EM; Jonas D; Kotchetkov R; Doerr HW; Cinatl J
    BMC Cancer; 2006 Dec; 6():294. PubMed ID: 17181871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bovine seminal ribonuclease exerts selective cytotoxicity toward neuroblastoma cells both sensitive and resistant to chemotherapeutic drugs.
    Cinatl J; Cinatl J; Kotchetkov R; Matousek J; Woodcock BG; Koehl U; Vogel JU; Kornhuber B; Schwabe D
    Anticancer Res; 2000; 20(2A):853-9. PubMed ID: 10810366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Onconase induces caspase-independent cell death in chemoresistant neuroblastoma cells.
    Michaelis M; Cinatl J; Anand P; Rothweiler F; Kotchetkov R; von Deimling A; Doerr HW; Shogen K; Cinatl J
    Cancer Lett; 2007 May; 250(1):107-16. PubMed ID: 17084521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased efficacy of aphidicolin killing of human neuroblastoma cells in vitro by encapsulation in liposomes.
    Cinatl J; Hernáiz Driever P; Cinatl J; Rückert DG; Gümbel HO; Rabenau H; Kornhuber B; Doerr HW
    Neoplasma; 1997; 44(2):91-5. PubMed ID: 9201287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bovine seminal ribonuclease selectively kills human multidrug-resistant neuroblastoma cells via induction of apoptosis.
    Cinatl J; Cinatl J; Kotchetkov R; Vogel JU; Woodcock BG; Matousek J; Pouckova P; Kornhuber B
    Int J Oncol; 1999 Nov; 15(5):1001-9. PubMed ID: 10536185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrin Gels Entrapment of a Poly-Cyclodextrin Nanocarrier as a Doxorubicin Delivery System in an Orthotopic Model of Neuroblastoma: Evaluation of In Vitro Activity and In Vivo Toxicity.
    Viale M; Vecchio G; Monticone M; Bertone V; Giglio V; Maric I; Cilli M; Bocchini V; Profumo A; Ponzoni M; Emionite L; Rocco M
    Pharm Res; 2019 Jun; 36(8):115. PubMed ID: 31161432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased malignant behavior in neuroblastoma cells with acquired multi-drug resistance does not depend on P-gp expression.
    Kotchetkov R; Driever PH; Cinatl J; Michaelis M; Karaskova J; Blaheta R; Squire JA; Von Deimling A; Moog J; Cinatl J
    Int J Oncol; 2005 Oct; 27(4):1029-37. PubMed ID: 16142320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential role of RIP1 in Smac mimetic-mediated chemosensitization of neuroblastoma cells.
    Czaplinski S; Abhari BA; Torkov A; Seggewiß D; Hugle M; Fulda S
    Oncotarget; 2015 Dec; 6(39):41522-34. PubMed ID: 26575016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent human cytomegalovirus infection induces drug resistance and alteration of programmed cell death in human neuroblastoma cells.
    Cinatl J; Cinatl J; Vogel JU; Kotchetkov R; Driever PH; Kabickova H; Kornhuber B; Schwabe D; Doerr HW
    Cancer Res; 1998 Jan; 58(2):367-72. PubMed ID: 9443419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53.
    Van Maerken T; Ferdinande L; Taildeman J; Lambertz I; Yigit N; Vercruysse L; Rihani A; Michaelis M; Cinatl J; Cuvelier CA; Marine JC; De Paepe A; Bracke M; Speleman F; Vandesompele J
    J Natl Cancer Inst; 2009 Nov; 101(22):1562-74. PubMed ID: 19903807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with onconase, an antitumor ribonuclease.
    Rybak SM; Pearson JW; Fogler WE; Volker K; Spence SE; Newton DL; Mikulski SM; Ardelt W; Riggs CW; Kung HF; Longo DL
    J Natl Cancer Inst; 1996 Jun; 88(11):747-53. PubMed ID: 8637029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel MDM2 inhibitor SAR405838 (MI-773) induces p53-mediated apoptosis in neuroblastoma.
    Lu J; Guan S; Zhao Y; Yu Y; Wang Y; Shi Y; Mao X; Yang KL; Sun W; Xu X; Yi JS; Yang T; Yang J; Nuchtern JG
    Oncotarget; 2016 Dec; 7(50):82757-82769. PubMed ID: 27764791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin-loaded Fab' fragments of anti-disialoganglioside immunoliposomes selectively inhibit the growth and dissemination of human neuroblastoma in nude mice.
    Pastorino F; Brignole C; Marimpietri D; Sapra P; Moase EH; Allen TM; Ponzoni M
    Cancer Res; 2003 Jan; 63(1):86-92. PubMed ID: 12517782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.